David Planchard, Thoracic Oncologist, Professor at University Paris Saclay and Head of Thoracic Cancer Group at Gustave Roussy, shared a post by ACS Journal Cancer on X, adding:
“Thank you ACS Journal Cancer for the opportunity to publish this review with my colleague Claudia Parisi on BRAF lung cancer updates!”
Quoting ACS Journal Cancer‘s post:
“Available Open Access from our Targeted Therapies in NSCLC supplement
BRAF in non–small cell lung cancer: From molecular mechanisms to clinical practice.”
Authors: David Planchard and Claudia Parisi
